Inventurus Knowledge Solutions | Business Upturn

IKS Health to acquire TruBridge for $26.25 per share to enhance rural healthcare access

Arunika Jain — Thu, 23 Apr 2026 16:23:23 +0000

Inventurus Knowledge Solutions (IKS Health) has announced a definitive agreement to acquire TruBridge, a leading provider of healthcare technology solutions for rural and community hospitals, for $26.25 per share in cash. This strategic acquisition aims to bolster access to high-quality healthcare and support clinicians and hospitals serving communities across the United States.

The acquisition will merge IKS Health’s comprehensive care enablement capabilities with TruBridge’s expertise in revenue cycle management and electronic health record solutions, enhancing local healthcare systems. This integration is expected to allow patients to receive essential care closer to home and improve care delivery across both ambulatory and acute care settings.

Post-acquisition, the combined entity will focus on continuous improvement and connected workflows in rural healthcare, incorporating agentic artificial intelligence with human expertise to address complex operational challenges. The platform is designed to become increasingly intelligent and efficient by integrating a broader range of clinical and financial data, ensuring financial resilience and advanced support for community hospitals and medical groups.

Sachin K. Gupta, Founder and Global CEO of IKS Health, stated, “By welcoming TruBridge, IKS Health is extending its proven, clinician-first experience to the vital rural and community hospital market. This new entity supports our long-term vision of building a comprehensive care ecosystem for all types of healthcare organisations.”

Chris Fowler, President and CEO of TruBridge, expressed enthusiasm for the merger, highlighting the shared passion for improving provider experiences and financial results, ultimately leading to healthier lives and positive patient outcomes.

The acquisition has received approval from the Boards of Directors of IKS Health, IKS, and TruBridge and is expected to close in the third quarter of 2026, subject to customary closing conditions, including shareholder approvals and regulatory notifications. TruBridge’s largest shareholders, representing approximately 27% of the outstanding shares, have agreed to vote in favour of the transaction.

IKS will finance the acquisition primarily through new indebtedness, including a term loan underwritten by Citibank, JPMorganChase, and Deutsche Bank.

Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).

Inventurus Knowledge Solutions to acquire Trubridge for USD 565 million

Business Desk — Thu, 23 Apr 2026 13:28:26 +0000

Inventurus Knowledge Solutions Limited has announced that its wholly owned subsidiary, Inventurus Knowledge Solutions, Inc. (IKS Inc.), will acquire 100% of the shareholding in Trubridge Inc. for a total consideration of up to USD 565 million. The acquisition will be executed through a merger of IKS Next Horizon, Inc., a Delaware corporation and wholly-owned subsidiary of IKS Inc., with Trubridge, pursuant to a plan of merger in accordance with Delaware law.

The acquisition, which is subject to customary adjustments for net debts and selling expenses, will result in Trubridge becoming a wholly owned subsidiary of IKS Inc., and an indirect subsidiary of Inventurus Knowledge Solutions Limited. The transaction is expected to be completed within 180 days from April 23, 2026.

Trubridge Inc., a leading healthcare IT and revenue cycle management services provider in the United States, reported a turnover of USD 347 million. The acquisition aims to diversify Inventurus Knowledge Solutions’ business into the SaaS EHR segment and enhance its integrated suite of EMR and Care enablement platform solutions.

The acquisition will be funded through a financing arrangement of up to USD 670 million, proposed to be availed by IKS Inc. from lenders including Citibank N.A., Deutsche Bank AG Singapore Branch, and JPMorgan Chase Bank, N.A., Hong Kong Branch. The financing will also support other purposes as outlined in the facilities agreement.

The security package for the financing will include pledges over the entire shareholding held by the company in IKS Inc., and security interests over substantially all assets of IKS Inc., Aquity Holdings, Inc., Aquity Solutions, LLC, and the Target post-acquisition. Corporate guarantees will also be provided by the company for up to 1.05x of the aggregate amount of the commitments under the facilities.

Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).

Inventurus Knowledge Solutions acquires 29,541 shares of subsidiary for USD 19 million

Arunika Jain — Fri, 27 Mar 2026 14:38:11 +0000

Inventurus Knowledge Solutions has announced the acquisition of 29,541 shares in its wholly owned subsidiary, Inventurus Knowledge Solutions, Inc. This acquisition represents the first tranche of investment, amounting to USD 19,000,476.

The company had previously disclosed on March 13, 2026, that its Board had approved further investment in the subsidiary. This recent acquisition aligns with the provisions of Regulation 30(7) of the SEBI LODR Regulations, continuing from the earlier disclosure.

The investment underscores Inventurus Knowledge Solutions’ commitment to strengthening its subsidiary’s operations and expanding its business capabilities.

Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).

Inventurus Knowledge Solutions approves USD 40 million investment in subsidiary IKS Inc

Business Desk — Fri, 13 Mar 2026 14:50:23 +0000

Inventurus Knowledge Solutions has approved a further investment of up to USD 40 million in its wholly owned subsidiary, Inventurus Knowledge Solutions Inc. (IKS Inc), as part of its ongoing strategic growth initiatives.

The decision was made during the company’s board meeting held on 13 March 2026. The investment will be executed in two tranches, with the first USD 20 million tranche priced at USD 643.19 per share, expected to be completed by 31 May 2026.

IKS Inc, based in the United States, specialises in providing technology-enabled solutions for healthcare providers through its care enablement platform. For the fiscal year 2024-25, IKS Inc reported a revenue of ₹6,941.11 million from operations and a total income of ₹6,996.92 million.

This transaction, conducted on an arm’s length basis, does not involve any interest from the company’s promoter group. The investment aims to support the business activities of IKS Inc, further enhancing its capabilities in the healthcare technology sector.

Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).